What is Trublood™?

Trublood is available exclusively at Hill Clinic - an official representative of Datar Cancer Genetics. It was developed by Datar Cancer Genetics based on the results of several clinical studies and validated on more than 40,000 samples. These included samples from asymptomatic subjects undergoing screening tests such as mammograms, colonoscopies, PAP smears, serum CA markers and other clinical examinations, as well as more than 17,000 samples from patients with various cancers and patients with benign diseases.

---

Who is the Trublood™ test for?

• symptomatic patients but the organ is difficult to access

• symptomatic individuals who have been advised an invasive tissue biopsy to check for mailgnancy
• patients where an invasive biopsy has been inconclusive or inconsistent with clinical observations

---

ADVANTAGES

The cutting-edge technology that powers Trublood™ is validated stringently to meet global standards.

Trublood in comparison with tissue biopsy

• Minimally invasive
• No pain, no stitches, no scars; only one blood draw
• No risk of tumour cell seeding
• No risk of injury to any organ / bleeding
• Suitable for radiologically undetectable tumors.
• Viable even if primary / metastasis are undetectable
• Provides real time data and covers all active sites
  Can be performed as often as necessary

---

The US Food and Drug Administration (FDA) has declared Datar Cancer Genetics' tests a breakthrough in medical technology of special significance.

---

METHOD

A blood biopsy detects circulating tumor cells (CTCs) and clusters of these cells separated from malignant tumors. Trucheck uses an epigenetically activating environment (EAM) that negatively enriches CTCs through the hallmark cancer evasion mechanism of apoptosis. When isolated PBMCs are treated with EAM, all non-malignant cells are eliminated, while all malignant cells, cells existing in the body tumor (CTCs), survive. These circulating tumor cell CTCs can be found in cancer patients and do not exist in healthy people. A blood biopsy can determine which organ these cells come from, ie. indicates the exact location of the tumor. Detected cancer cells are examined for number, size and characteristics, and the whole process takes only a few days. Blood biopsy enables extremely fast diagnosis and corresponding treatment of cancer in the earliest phase, which gives an optimal prognosis for the patient's survival.

AN ORGAN-SPECIFIC TEST CAN BE DONE ON:

Prostate	Breast	Cervix- SqCC
Face	Gallbladder	Head
Neck	Liver	Lung
Ovary	Pancreas	Stomach
Uterus	централна нервна система – глиома	Bladder
Colorectum	Esophagus	Thyroid
Kidney RCC

---

Trublood can complement, or if necessary, replace invasive biopsies.

You can see how to prepare for the test here..

Tests:

Trublood prostate	1100 EUR
Trublood Breast	1900 EUR
Trublood Lungs	1900 EUR
Trublood CNS	1900 EUR

SCHEDULE YOUR APPOINTMENT FOR AN EARLY CANCER SCREENING BLOOD TEST NOW: 024393131